Kitchen Staples

The "Ketone Rescue" Trials in Mild Cognitive Impairment

As the aging brain loses some ability to run on glucose, a specific type of fat appears to give it an alternative fuel source — and a 2025 trial tested exactly that idea.

Published August 23, 2026 · The Actual Research

The 'Ketone Rescue' Trials in Mild Cognitive Impairment
This article summarizes research on MCT oil supplementation. It is not medical advice and is not a substitute for medical care in diagnosed cognitive decline.

Medium-chain triglycerides break down into medium-chain fatty acids that the liver converts into ketone bodies (beta-hydroxybutyrate, acetoacetate) — an alternative brain fuel source that can bypass impaired glucose metabolism, sometimes called "ketone rescue" for aging or Alzheimer's-affected brains.

Key Findings

  • A 2025 RCT found MCT oil raised ketone levels and improved memory in mild cognitive impairment, vs. no change in placebo
  • In healthy young adults, a single dose improved inhibitory control; 4 weeks daily improved working memory
  • An Alzheimer's crossover trial found benefit specifically in people without the APOE4 genetic risk variant
  • This is supplementation research, not a substitute for medical care

The 2025 mild cognitive impairment trial

A 2025 randomized, double-blind, placebo-controlled trial in people with mild cognitive impairment found MCT oil supplementation increased serum ketone levels and improved memory performance, while the placebo group showed no cognitive improvement.1

Effects in healthy adults, and the APOE4 catch

Separately, a 2025 trial in healthy young adults found a single dose of MCTs improved inhibitory control, and a 4-week daily regimen improved working memory. A crossover trial in mild-to-moderate Alzheimer's found MCT supplementation improved cognition specifically in patients without the APOE4 genetic risk variant2 — an important subgroup distinction that means the benefit may not apply equally to everyone.

What this doesn't mean

This is supplementation research in specific, studied populations — not a substitute for medical care in diagnosed cognitive decline, and not proof that MCT oil works the same way for everyone regardless of genetic status.

The practical takeaway

  • The APOE4 finding matters — this isn't a guaranteed effect for every person
  • Talk to a doctor before using MCT oil as an intervention for cognitive symptoms, especially alongside other treatment
  • These trials used measured, controlled doses — not an "as much as you like" amount

Sources

  1. "MCT Oil Supplementation in Mild Cognitive Impairment." ClinicalTrials.gov, 2025. clinicaltrials.gov
  2. "MCT supplementation and cognition in Alzheimer's disease: APOE4 subgroup analysis." Alzheimer's & Dementia: Translational Research & Clinical Interventions. alz-journals.onlinelibrary.wiley.com

The Actual Research

We read the studies so the headline doesn't have to. Read more about how we source articles →